Patents by Inventor G. Stoll

G. Stoll has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210038669
    Abstract: Pharmaceutically effective compositions and methods for topically treating pain due to swelling or inflammation of fascia, tendons, or ligaments in a patient in need of treatment, thereof. The pharmaceutically effective composition consists essentially of: 68.6-29.4 parts by weight of a pharmaceutically acceptable excipient; 40.0-50.0 parts by weight DMSO; 1.0-5.0 parts by weight of an anesthetic, wherein the anesthetic is advantageously characterized as containing only lidocaine; and 1.2-3.2 parts by weight of an anti-inflammatory in 100 parts by weight of the pharmaceutically effective composition. In one embodiment, the anesthetic is advantageously 4.0 parts by weight Lidocaine. In one embodiment, the pharmaceutically acceptable excipient is 48.0 parts by weight, DMSO is 45 parts by weight, anesthetic is advantageously 4.0 parts by weight Lidocaine, Echinaceas is 1.0 part by weight and Arnica is 1.0 part by weight, and the condition causing pain of the foot is Plantar Fasciitis.
    Type: Application
    Filed: June 30, 2020
    Publication date: February 11, 2021
    Inventors: Robert Alonso, Lawrence G. Stoll
  • Patent number: 10744174
    Abstract: Pharmaceutically effective compositions and methods for topically treating pain due to swelling or inflammation of fascia, tendons, or ligaments in a patient in need of treatment, thereof. The pharmaceutically effective composition consists essentially of: 68.6-29.4 parts by weight of a pharmaceutically acceptable excipient; 40.0-50.0 parts by weight DMSO; 1.0-5.0 parts by weight of an anesthetic, wherein the anesthetic is advantageously characterized as containing only lidocaine; and 1.2-3.2 parts by weight of an anti-inflammatory in 100 parts by weight of the pharmaceutically effective composition. In one embodiment, the anesthetic is advantageously 4.0 parts by weight Lidocaine. In one embodiment, the pharmaceutically acceptable excipient is 48.0 parts by weight, DMSO is 45 parts by weight, anesthetic is advantageously 4.0 parts by weight Lidocaine, Echinaceas is 1.0 part by weight and Arnica is 1.0 part by weight, and the condition causing pain of the foot is Plantar Fasciitis.
    Type: Grant
    Filed: March 16, 2017
    Date of Patent: August 18, 2020
    Inventors: Robert Alonso, Lawrence G. Stoll
  • Patent number: 6985869
    Abstract: A digital prescription carrier and monitor system includes a pager sized carrier apparatus with an internal processor, a real-time clock/calendar, non-volatile memory, a communication port, a character display, and alert devices. Prescription data for one or more medications is stored within the carrier by a physician and downloaded by a pharmacist to fill the prescriptions called for. The carrier apparatus requires the entry of an decryption key to access prescription data within the carrier to prevent unauthorized access or tampering with the prescription data. The carrier apparatus also functions as a prescription reminder to the patient and records compliance with the prescription, since a switch must be operated to quiet an alert device activated when a scheduled medication dose is due.
    Type: Grant
    Filed: January 21, 2000
    Date of Patent: January 10, 2006
    Assignee: NextMed, LLC
    Inventors: Thomas G. Stoll, Karl P. Schmidt
  • Patent number: 6577877
    Abstract: A wireless infrared peripheral interface for a communication device having a cellular radio transceiver includes a peripheral interface. The peripheral interface includes at least one infrared signal source and at least one infrared detector. The signal source and detector are coupled with dispersing optics. An interface circuit is coupled to the infrared signal source and detector. A processor is coupled to the interface circuit, wherein the processor controls the interface circuit to process data signals that are conveyed through the infrared source and detector so as to communicate with a peripheral device that is proximate to the communication device. The dispersing optics reduces the dependency of optical alignment between the infrared data ports of the peripheral device and communication device.
    Type: Grant
    Filed: February 23, 2000
    Date of Patent: June 10, 2003
    Assignee: Motorola, Inc.
    Inventors: Michael L. Charlier, Thomas G. Stoll, Rachid M. Alameh, Michael W. Schellinger, Thomas R. Schirtzinger, Thomas E. Gitzinger, Jr., Hugh K. Smith
  • Patent number: 5606618
    Abstract: Reproduction accuracy of, for example a digital stereo audio signal, is improved by transmitting sample data as sub-signals such as frequency subband signals. In one or more subbands, corresponding components such as left and right stereo channels are combined so that only one composite signal is transmitted per subband. An indicator signal is transmitted, indicating which subbands are combined. Scale factor signals for all subbands, and for the relative intensity of the respective subband signals which were combined, may also be transmitted. In the receiver a subband signal is derived for each channel from the composite signal, before synthesis of the full channel signals which will be reproduced.
    Type: Grant
    Filed: December 27, 1993
    Date of Patent: February 25, 1997
    Assignee: U.S. Philips Corporation
    Inventors: Gerardus C. P. Lokhoff, Y. F. Dehery, G. Stoll, G. Theile
  • Patent number: 4548783
    Abstract: A stopper apparatus for use in blocking the unvalved nozzle of a cooling fluid filled nuclear reactor pressure vessel includes a plug, typically in the shape of a frusto-conical member having inflatable gaskets for sealing against a seat of generally unknown surface characteristics and means for positioning and urging the plug into position to seal the nozzle. The plug is typically positioned by suspension cables whereby the apparatus can be temporarily inserted and removed from the pressure vessel. The urging means is generally a two-way hydraulically driven jack controlled by remotely-actuated hydarulic lines. The apparatus is a tool which permits temporary sealing of a submerged outlet in a reactor vessel to permit maintenance on a fluid recirculation loop.
    Type: Grant
    Filed: March 10, 1982
    Date of Patent: October 22, 1985
    Assignee: General Electric Company
    Inventors: Charles A. Dalke, Bradley G. Stoll
  • Patent number: 4468172
    Abstract: A jet pump plug for a multi-nozzle jet pump is disclosed wherein the nozzles are accessible through a relatively small opening in the pump structure. The plug comprises a plurality of sections, each including a closure plate and a lever coupled thereto. Each plug section is constructed so as to allow that section to be separately introduced into the opening to the vicinity of the nozzles from a location which may be remote from the pump. The closure plates are manipulated through their attached levers from a remote location to the end of sealing the nozzles with them. The first plug section introduced through the opening includes means for alignment relative to the jet pump structure so as to orient its closure plate with respect to the nozzles. The remaining plug section is supported by the first plug section upon being introduced into the opening.
    Type: Grant
    Filed: March 8, 1983
    Date of Patent: August 28, 1984
    Assignee: General Electric Company
    Inventors: Robert C. Dixon, Ronald D. Poland, Bradley G. Stoll, Bob Y. Okashima